Patrick P. Gleason - Concepedia

Author

Patrick P. Gleason

Five Prime Therapeutics (United States)

Also Known As

Justin Gatwood, Kristin Gillard, P. Gleason, P.P. Gleason, Patrick Gleason, Patrick P Gleason, Patrick P. Gleason

Publications

Citations

H-Index

Concepts

All Affiliations

Five Prime Therapeutics (United States)University of Minnesota University of Pittsburgh Blue Cross and Blue Shield of Kansas City Gleason (United States)

About

Patrick P. Gleason is an author at Five Prime Therapeutics (United States) specializing in medicine, health policy, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	266
2	Public Health	4	4	103
3	Education	1	1	18
4	Health Sciences	1	1	34
5	Humanities	1	1	18

Patrick P. Gleason

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Associations Between Initial Antimicrobial Therapy and Medical Outcomes for Hospitalized Elderly Patients With Pneumonia Patrick P. Gleason, Thomas P. Meehan, Jonathan M. Fine, Archives of Internal Medicine	1999	501
Medical Outcomes and Antimicrobial Costs With the Use of the American Thoracic Society Guidelines for Outpatients With Community-Acquired Pneumonia Patrick P. Gleason JAMA	1997	217
Correlates and prevalence of benzodiazepine use in community-dwelling elderly Patrick P. Gleason, Richard Schulz, Nicholas L. Smith, Journal of General Internal Medicine Substance AbuseAgingPsychiatryGeriatricsDementia	1998	111
Real-world persistence and adherence to glucagon-like peptide-1 receptor agonists among obese commercially insured adults without diabetes Patrick P. Gleason, Benjamin Y. Urick, Landon Marshall, Journal of Managed Care & Specialty Pharmacy	2024	103
Rosiglitazone and Pioglitazone Utilization from January 2007 Through May 2008 Associated With Five Risk-Warning Events Catherine I. Starner, Jeremy A Schafer, Alan Heaton, Journal of Managed Care Pharmacy	2008	102
Variations in Antimicrobial Use and Cost in More Than 2,000 Patients with Community-acquired Pneumonia Ken Gilbert, Patrick P. Gleason, Daniel E. Singer, The American Journal of Medicine	1998	95
Elevation of Hepatic Transaminases after Enoxaparin Use: Case Report and Review of Unfractionated and Low‐Molecular‐Weight Heparin‐Induced Hepatotoxicity Melissa K. Carlson, Patrick P. Gleason, Soma Sen Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	2001	87
Association of Prescription Abandonment with Cost Share for High-Cost Specialty Pharmacy Medications Patrick P. Gleason, Catherine I. Starner, Brent W. Gunderson, Journal of Managed Care Pharmacy	2009	86
Health Plan Utilization and Costs of Specialty Drugs Within 4 Chronic Conditions Patrick P. Gleason, G. Caleb Alexander, Catherine I. Starner, Journal of Managed Care Pharmacy	2013	52
Specialty Drug Coupons Lower Out-Of-Pocket Costs And May Improve Adherence At The Risk Of Increasing Premiums Catherine I. Starner, G. Caleb Alexander, Kevin Bowen, Health Affairs Specialty PharmacyMay Improve AdherencePharmacotherapyPrimary CarePreventive Medicine	2014	45

Page 1